Profile of Quizartinib for the Treatment of Adult Patients With Relapsed/Refractory FLT3-ITD-Positive Acute Myeloid Leukemia: Evidence to Date
Cancer Management and Research - New Zealand
doi 10.2147/cmar.s196568
Full Text
Open PDFAbstract
Available in full text
Categories
Date
January 1, 2020
Authors
Publisher
Informa UK Limited